Ohr Pharmaceutical Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 5

  • Investments
  • 3

Ohr Pharmaceutical General Information

Description

Ohr Pharmaceutical Inc is a US-based pharmaceutical company which focuses on the development of novel therapeutics and delivery technologies for the treatment of ocular disease. The lead product of the company is topical Squalamine is a novel therapeutic product which provides non-invasive therapy to improve visual outcomes. Its product pipeline includes SQUALAMINE LACTATE OPHTHALMIC SOLUTION 0.2%, SKS sustained release ocular drug delivery platform technology, Animal Model for Dry-AMD, and Non-Ophthalmology Assets.

Contact Information

Website
www.ohrpharmaceutical.com
Formerly Known As
BBM Holdings, Inc.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 800 Third Avenue, 11th Floor
  • New York, NY 10022
  • United States
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Acquirer
NeuBase Therapeutics
Vertical(s)
Life Sciences
Corporate Office
  • 800 Third Avenue, 11th Floor
  • New York, NY 10022
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ohr Pharmaceutical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ohr Pharmaceutical‘s full profile, request access.

Request a free trial

Ohr Pharmaceutical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Ohr Pharmaceutical Inc is a US-based pharmaceutical company which focuses on the development of novel therapeutics and d
Pharmaceuticals
New York, NY

Boston, MA
 

Somerville, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ohr Pharmaceutical Competitors (20)

One of Ohr Pharmaceutical’s 20 competitors is PureTech Health, a Formerly VC-backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
PureTech Health Formerly VC-backed Boston, MA
Genetix Biotherapeutics Private Equity-Backed Somerville, MA
Pliant Therapeutics Formerly VC-backed San Francisco, CA
Rein Therapeutics Formerly VC-backed Austin, TX
Gelesis Formerly VC-backed Calimera, Italy
You’re viewing 5 of 20 competitors. Get the full list »

Ohr Pharmaceutical Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Ohr Pharmaceutical‘s full profile, request access.

Request a free trial

Ohr Pharmaceutical Investments & Acquisitions (3)

Ohr Pharmaceutical’s most recent deal was a Reverse Merger with NeuBase Therapeutics. The deal was made on 15-Jul-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
NeuBase Therapeutics 15-Jul-2019 Reverse Merger Drug Discovery
SKS Ocular 15-May-2014 Merger/Acquisition Drug Delivery
DepYmed 01-Jan-2014 Joint Venture Drug Discovery
To view Ohr Pharmaceutical’s complete investments and acquisitions history, request access »

Ohr Pharmaceutical Exits (1)

Ohr Pharmaceutical’s most recent exit was on 15-Jul-2019 from NeuBase Therapeutics. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
NeuBase Therapeutics 15-Jul-2019 Completed
To view Ohr Pharmaceutical’s complete exits history, request access »

Ohr Pharmaceutical Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
SKS Ocular San Diego, CA 2010

Ohr Pharmaceutical FAQs

  • When was Ohr Pharmaceutical founded?

    Ohr Pharmaceutical was founded in 2009.

  • Where is Ohr Pharmaceutical headquartered?

    Ohr Pharmaceutical is headquartered in New York, NY.

  • What industry is Ohr Pharmaceutical in?

    Ohr Pharmaceutical’s primary industry is Pharmaceuticals.

  • Is Ohr Pharmaceutical a private or public company?

    Ohr Pharmaceutical is a Private company.

  • What is the current valuation of Ohr Pharmaceutical?

    The current valuation of Ohr Pharmaceutical is .

  • What is Ohr Pharmaceutical’s current revenue?

    The current revenue for Ohr Pharmaceutical is .

  • How much funding has Ohr Pharmaceutical raised over time?

    Ohr Pharmaceutical has raised $50.7M.

  • Who are Ohr Pharmaceutical’s investors?

    Broadfin Capital and Deerfield Management have invested in Ohr Pharmaceutical.

  • Who are Ohr Pharmaceutical’s competitors?

    PureTech Health, Genetix Biotherapeutics, Pliant Therapeutics, Rein Therapeutics, and Gelesis are some of the 20 competitors of Ohr Pharmaceutical.

  • When was Ohr Pharmaceutical acquired?

    Ohr Pharmaceutical was acquired on 12-Jul-2019.

  • Who acquired Ohr Pharmaceutical?

    Ohr Pharmaceutical was acquired by NeuBase Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process